Gilead CEO expects remdesivir to effectively treat Covid strains found in UK, South Africa

"I expect remdesivir with these variants will continue to make an impact on patients," Gilead Sciences CEO Daniel O'Day told CNBC.

from Health and Science https://ift.tt/2MV5FJZ
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH